The food delivery service reportedly expects to achieve a valuation of more than $2.6bn when it floats, having secured permission for Amazon to invest earlier this year.

CU Boulder's heart disease drug developer MyoKardia has been picked up by BMS after finishing clinical trials on its lead asset.

Dana-Farber Cancer Institute's cancer therapy developer raised $182m in an upsized IPO where it floated above its range.

The Sistema-backed e-commerce marketplace has confidentially filed for an initial public offering in the US that would value it at $3bn to $5bn.

Tencent-backed online gaming platform developer Roblox is in talks over an IPO or direct listing at a valuation of up to $8bn.

The Roche, Novartis and Kraft Group-backed cancer therapy developer raised $182m in an upsized IPO where it floated above its range.

Microsoft unit M12 has exited game developer SuperAwesome in an acquisition of undisclosed size by Epic Games.

Sompo, Fujitsu and Relx-backed Palantir went public yesterday and fetched a $20.6bn valuation – only marginally above the $20.3bn it was worth in 2015.

The cybersecurity company was once listed on NYSE, before an acquisition by Intel and a subsequent spinoff, and has now put a $100m placeholder figure on its planned IPO.